John Christopher Lindon
Directeur/Membre du Conseil chez Metabometrix Ltd.
Postes actifs de John Christopher Lindon
Sociétés | Poste | Début | Fin |
---|---|---|---|
Metabometrix Ltd.
Metabometrix Ltd. Miscellaneous Commercial ServicesCommercial Services Metabometrix Ltd. provides metabonomics research services. It uses nuclear magnetic resonance technology to generate and interpret high-density metabolic data using robotic flow-injection technology. The firm markets its metabonomic technologies to pharmaceutical and biotechnology companies. Metabometrix was founded by Jeremy Kirk Nicholson in 2000 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Imperial College London | Corporate Officer/Principal | - | - |
Historique de carrière de John Christopher Lindon
Anciens postes connus de John Christopher Lindon
Sociétés | Poste | Début | Fin |
---|---|---|---|
Wellcome Research Laboratories | Corporate Officer/Principal | 01/01/1995 | 01/01/1995 |
University of London | Corporate Officer/Principal | - | - |
Formation de John Christopher Lindon
University of Birmingham | Undergraduate Degree |
Statistiques
Internationale
Royaume-Uni | 5 |
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sectorielle
Consumer Services | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Metabometrix Ltd.
Metabometrix Ltd. Miscellaneous Commercial ServicesCommercial Services Metabometrix Ltd. provides metabonomics research services. It uses nuclear magnetic resonance technology to generate and interpret high-density metabolic data using robotic flow-injection technology. The firm markets its metabonomic technologies to pharmaceutical and biotechnology companies. Metabometrix was founded by Jeremy Kirk Nicholson in 2000 and is headquartered in London, the United Kingdom. | Commercial Services |
Wellcome Research Laboratories |
- Bourse
- Insiders
- John Christopher Lindon
- Expérience